Europe Pharmacovigilence Market is projected to reach USD 2.58 Billion by 2023
Major pharmaceutical companies are involved in extensive R&D initiatives for development of innovative therapeutic molecules.
(EMAILWIRE.COM, September 25, 2018 ) Overview:
In the year 2018, Europe Pharmacovigilence Market was valued at USD 1.34 Billion. By the year 2023, it is expected to reach USD 2.58 Billion at pace of 13.9% CAGR.
Pharmacovigilance is a safety and efficacy study of a medical product or drug. It is a science associated with the detection, collection, prevention and evaluation of adverse effects that are related to the drug or medical product. Pharmacovigilance plays an important role to analyze and determine the side effects of the drug, which negatively affects the efficiency of the drug and vice versa. It includes preclinical research, drug discovery and development, post-market surveillance and clinical research. Pharmacovigilance follows every phase of a drug cycle from preclinical development to post-marketing surveillance.
View sample and decide: https://www.marketdataforecast.com/market-reports/europe-pharmacovigilence-market-7806/request-sample
Underlying Causes
The growth for Pharmacovigilence market is driven due to factors like rising prevalence for chronic diseases, increasing investments for R&D activities, introduction of new therapeutics. In addition, increasing focus for drug development, and rising demand for quality drugs and medicines are expected to drive the market growth. However, stringent regulatory policies are the major restraining factor for Europe Pharmacovigilence Market during the forecast period.
To know more read: https://www.marketdataforecast.com/market-reports/europe-pharmacovigilence-market-7806/
Geographic Segmentation:
Based on geography the Europe Pharmacovigilence market has been primarily divided into United Kingdom, France, Spain, Italy and Germany. Europe is accounted as the second largest market for Pharmacovigilence market due to rising demand for personalized medicines and increasing level of competition from biosimilars and generics are the driving factors in this region.
Get your customized report: https://www.marketdataforecast.com/market-reports/europe-pharmacovigilence-market-7806/customize-report
Key Players:
Leading companies for Europe Pharmacovigilence market are Boehringer Ingelheim, Accenture, Bristol-Myers Squibb, Covance, ICON, PAREXEL, Quintiles, United BioSource, Synowlwedge and Cognizant Technology Solutions Corporation.
In the year 2018, Europe Pharmacovigilence Market was valued at USD 1.34 Billion. By the year 2023, it is expected to reach USD 2.58 Billion at pace of 13.9% CAGR.
Pharmacovigilance is a safety and efficacy study of a medical product or drug. It is a science associated with the detection, collection, prevention and evaluation of adverse effects that are related to the drug or medical product. Pharmacovigilance plays an important role to analyze and determine the side effects of the drug, which negatively affects the efficiency of the drug and vice versa. It includes preclinical research, drug discovery and development, post-market surveillance and clinical research. Pharmacovigilance follows every phase of a drug cycle from preclinical development to post-marketing surveillance.
View sample and decide: https://www.marketdataforecast.com/market-reports/europe-pharmacovigilence-market-7806/request-sample
Underlying Causes
The growth for Pharmacovigilence market is driven due to factors like rising prevalence for chronic diseases, increasing investments for R&D activities, introduction of new therapeutics. In addition, increasing focus for drug development, and rising demand for quality drugs and medicines are expected to drive the market growth. However, stringent regulatory policies are the major restraining factor for Europe Pharmacovigilence Market during the forecast period.
To know more read: https://www.marketdataforecast.com/market-reports/europe-pharmacovigilence-market-7806/
Geographic Segmentation:
Based on geography the Europe Pharmacovigilence market has been primarily divided into United Kingdom, France, Spain, Italy and Germany. Europe is accounted as the second largest market for Pharmacovigilence market due to rising demand for personalized medicines and increasing level of competition from biosimilars and generics are the driving factors in this region.
Get your customized report: https://www.marketdataforecast.com/market-reports/europe-pharmacovigilence-market-7806/customize-report
Key Players:
Leading companies for Europe Pharmacovigilence market are Boehringer Ingelheim, Accenture, Bristol-Myers Squibb, Covance, ICON, PAREXEL, Quintiles, United BioSource, Synowlwedge and Cognizant Technology Solutions Corporation.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results